Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
6.78 +0.13 / +1.95%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
6.78 0.00 / 0.00%
 
Volume: 4.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2013
Quarter 1
2014
Quarter 2
2014
Quarter 3
2014
Revenue and IncomeNet Revenues3.0M1.8M1.5M41.7M
 
 
 
 
 
Cost of Goods Sold316.0K172.0K327.0K329.0K
 
 
 
 
 
Depreciation And Amortization165.0K144.0K133.0K142.0K
 
 
 
 
 
 
Operating ExpensesGross Income2.5M1.5M1.0M41.2M
 
 
 
 
 
General Expenses10.3M10.3M11.7M10.6M
 
 
 
 
 
Research And Development7.5M6.9M7.8M6.7M
 
 
 
 
 
Total Operating Expenses10.8M10.6M12.2M11.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.8M-8.8M-10.7M30.6M
 
 
 
 
 
Extraordinary Credit------7.3M
 
 
Extraordinary Charge-1.1M-500.0K-400.0K-1.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.9M-9.3M-11.1M36.7M
 
 
 
 
 
Income Taxes-362.0K0.00-1.0K-227.0K
 
 
 
 
Net Income-8.6M-9.3M-11.1M37.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS60.8M64.0M63.7M69.6M
 
 
 
 
 
Shares To Calculate EPS Diluted60.8M64.0M63.7M72.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.14-$0.15-$0.17$0.51
 
 
 
 
 
EPS Diluted-$0.14-$0.15-$0.17$0.51
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account